CN103182066A - Medicament for treating canker sores - Google Patents

Medicament for treating canker sores Download PDF

Info

Publication number
CN103182066A
CN103182066A CN 201310111411 CN201310111411A CN103182066A CN 103182066 A CN103182066 A CN 103182066A CN 201310111411 CN201310111411 CN 201310111411 CN 201310111411 A CN201310111411 A CN 201310111411A CN 103182066 A CN103182066 A CN 103182066A
Authority
CN
China
Prior art keywords
parts
herba
radix
medicament
folium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201310111411
Other languages
Chinese (zh)
Inventor
张爱香
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201310111411 priority Critical patent/CN103182066A/en
Publication of CN103182066A publication Critical patent/CN103182066A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating canker sores, which comprises the following components in weight proportion: 5-10 parts of figwort root, 10-20 parts of dried ginger, 20-30 parts of dogwood fruit, 10-20 parts of balloonflower root, 15-25 parts of Chinese goldthread, 5-15 parts of chrysanthemum flower, 10-30 parts of goldenrod, 1-15 parts of henbane seed, 10-20 parts of Chinese ephedra, 15-30 parts of pyrrosia leaf, 20-30 parts of tabasheer, 1-20 parts of morinda root, 1-20 parts of celandine, 10-25 parts of rhodiola root, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of common jasminorange, 10-20 parts of pharbitits seed, 15-20 parts of inula herb, 15-30 parts of Chinese tamarisk, 10-20 parts of Chinese clinopodium herb, 10-25 parts of senna leaf, 5-15 parts of aleppo avens, 1-20 parts of Chinese angelica root, 15-25 parts of dahurian rhododendron leaf, 15-25 parts of potentilla discolor, 10-20 parts of sappan wood, 15-25 parts of poria cocos, 20-30 parts of eupatorium, 1-20 parts of gordon euryale seed and 10-25 parts of rhododendron molle. As all the components of the medicament for treating canker sores are natural materials, the medicament is better in safety, clear in curative effect and suitable for large-scale clinical popularization.

Description

A kind of medicament for the treatment of oral ulcer
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of oral ulcer.
Background technology
Oral ulcer is a kind of aphtha that occurs in the oral cavity thin film, and the lighter's causalgia is obvious, influences diet; Heavy then produce mucosa adenitis or necrosis, the course of disease is slow, leaves cicatrix after more.The treatment oral ulcer has methods such as antibiotic medicine for oral administration, mealy medicine external application at present, but therapeutic effect is not obvious, particularly uses application, and the pain increased, sialorrhea is more than, and patient is difficult to accept.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of oral ulcer.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of oral ulcer, it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Radix Rhodiolae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Cacumen Tamaricis 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Angelicae Sinensis 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Lignum Sappan 10-20 part, Poria 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the medicament for the treatment of oral ulcer of the present invention is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts in Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Radix Rhodiolaes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Cacumen Tamariciss, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Angelicae Sinensis, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Lignum Sappans, 25 parts in Poria, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of oral ulcer of the present invention all are natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further specify the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
Embodiment decoction of the present invention
Take by weighing Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, Rhizoma Coptidis 21 grams, Flos Chrysanthemi 13 grams, Herba Solidaginis 28 grams, Semen Hyoscyami 11 grams, Herba Ephedrae 17 grams, Folium Pyrrosiae 24 grams, Concretio Silicea Bambusae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Radix Rhodiolae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Cacumen Tamaricis 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Angelicae Sinensis 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Lignum Sappan 14 grams, Poria 25 grams, Herba Eupatorii Lindleyani 26 grams, Semen Euryales 16 grams and Flos Rhododendri Mollis 24 grams, add water 2000 milliliters, in the flask of condensing tube is housed, heated 4 hours down at 80 ℃, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
Diagnostic criteria
1, light-duty oral ulcer: the most common, account for 80%, general diameter 2-4mm, round or oval, clear on every side, isolated being dispersed in, number is few, and each 1~5 is not waited, good sending out in the relatively poor zone of keratinization degree, as lip cheek mucosa, the gum palatine that the keratinization degree is high is less, during outbreak ulcer have " recessed; red; Huang; feature bitterly ", i.e. ulcer concavity, substrate is not hard, periphery is with the congested blush band of about 1mm, and the surface is covered with light yellow pseudomembrane, and the causalgia sense is obvious, infecting serious time companion's submandibular lymph nodes swells and ache, heating generally continues 1-2 week, and the intermission is different in size, because the thorn Severe Pain influences language, feed, mood, thus quality of life is had a negative impact; 2, heavy oral ulcer: ulcer is big and dark during outbreak, " like the crater " diameter 10-30mm, the dark tela submucosa that reaches is until the flesh layer, and periphery is red and swollen to swell, and the substrate of laying one's hand on is harder, but neat in edge is clear, normal single generation, stage of attack, can reach a month surplus even several months, and pain is heavier, more can stay cicatrix after, rare; 3, herpes sample oral ulcer: ulcer is little, and diameter 2mm can reach more than the dozens of and many, but symptoms such as companioned with headache, low grade fever, general malaise, regional nodes's enlargement are rare.
Close patient's 50 examples of the standard of stating of selector, male 25 examples wherein, women 25 examples; 25~52 years old age, average 34 years old.
Use the decoction for preparing among the embodiment to treat, every day 3 times, each oral 50 milliliters.Treating 3 days is a course for the treatment of.
Criterion of therapeutical effect: pain disappears, the oral ulcer surface healing.
Through the observation of 1 course for the treatment of, find that the equal pain of whole patients disappears, the oral ulcer surface healing, and during whole treatment, do not observe tangible untoward reaction.

Claims (3)

1. medicament for the treatment of oral ulcer, it is characterized in that it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Radix Rhodiolae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Cacumen Tamaricis 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Angelicae Sinensis 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Lignum Sappan 10-20 part, Poria 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of oral ulcer according to claim 1, it is characterized in that it is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts in Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Radix Rhodiolaes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Cacumen Tamariciss, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Angelicae Sinensis, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Lignum Sappans, 25 parts in Poria, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
3. the medicament for the treatment of oral ulcer according to claim 1 is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
CN 201310111411 2013-03-22 2013-03-22 Medicament for treating canker sores Pending CN103182066A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201310111411 CN103182066A (en) 2013-03-22 2013-03-22 Medicament for treating canker sores

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201310111411 CN103182066A (en) 2013-03-22 2013-03-22 Medicament for treating canker sores

Publications (1)

Publication Number Publication Date
CN103182066A true CN103182066A (en) 2013-07-03

Family

ID=48673681

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201310111411 Pending CN103182066A (en) 2013-03-22 2013-03-22 Medicament for treating canker sores

Country Status (1)

Country Link
CN (1) CN103182066A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105876090A (en) * 2015-01-07 2016-08-24 牙韩温 Nutritional and health-care lick bricks preventing and curing goat oral ulcers and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105876090A (en) * 2015-01-07 2016-08-24 牙韩温 Nutritional and health-care lick bricks preventing and curing goat oral ulcers and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101129673A (en) Pure traditional Chinese medicine formulated product for preventing and treating coccidiosis
CN102488778A (en) Chinese traditional medicine preparation for treating upper respiratory tract infection of livestock and preparation method thereof
CN102698233A (en) Traditional Chinese medicine mixture for treating cold-fluid heat type child capillary bronchitis and preparation method of same
CN103656579A (en) Traditional Chinese medicine composition for relieving cough
CN103182066A (en) Medicament for treating canker sores
CN103142959A (en) Medicament for treating urticaria
CN1144097A (en) Longzhusan powder
CN102600365B (en) Drug for treatment of oral ulcers
WO2011016652A2 (en) Composition for controlling anal fistulae and method for preparing same
CN103142985B (en) Medicament for treating chronic gastritis
CN101683476A (en) Taditional Chinese medicine preparation for treating throat edema pain
CN102552711B (en) Traditional Chinese medicine composition for treating hypertension
CN1237994C (en) Medicine composition for preparing canker and preparing method thereof
CN110237119A (en) A kind of pharmaceutical composition that treating mucous membrane of mouth class disease and preparation method and purposes
CN103948736B (en) The compound Chinese medicinal preparation for the treatment of hepatocarcinoma and production method thereof
CN103272192B (en) Medicament for treating perianal abscess
CN114569690B (en) Traditional Chinese medicine composition for treating helicobacter pylori infectious gastritis
CN103142972B (en) Medicine for treating children dermatosis
CN103157090A (en) Medicament for treating diarrhea
CN103816413A (en) Traditional Chinese medicinal preparation for treating postoperative pneumonia
CN102688298A (en) Chinese traditional medicine lotion for preventing and treating varicella and preparation method thereof
CN1099886C (en) Biaining as one medicine for nasopharyngeal cancer
CN114344368A (en) Application of nauclea officinalis extract in preparation of medicine for preventing and treating oral ulcer
CN103142955A (en) Medicine for treating cold
CN105521326A (en) Traditional Chinese medicine for treating hebra prurigo

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130703